Drugs.com - New Drug Approvals

FDA Approves TNKase (tenecteplase) for the Treatment of Acute Ischemic Stroke in Adults

South San Francisco, CA -- March 3, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving...

Mar 4, 2025 - 00:17
 0
FDA Approves TNKase (tenecteplase) for the Treatment of Acute Ischemic Stroke in Adults
South San Francisco, CA -- March 3, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving...
Read More

Tags:

Previous Article

Pullman Hai Phong Grand Hotel Debuts as the Flagship of Northern Vietnam, Redefi...

Next Article

CDC IDs Trends in Pediatric Flu Deaths With Influenza-Linked Encephalopathy

Related Posts

FDA Approves Vtama (tapinarof) Cream for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

FDA Approves Vtama (tapinarof) Cream for the Treatment ...

Feb 9, 2025  0

FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)

FDA Approves Genentech’s Evrysdi Tablet as First and On...

Feb 13, 2025  0

Indivior Announces FDA Approval of Label Changes for Sublocade (buprenorphine extended-release) Injection

Indivior Announces FDA Approval of Label Changes for Su...

Mar 3, 2025  0